Escrito por estudiantes que aprobaron Inmediatamente disponible después del pago Leer en línea o como PDF ¿Documento equivocado? Cámbialo gratis 4,6 TrustPilot
logo-home
Document preview thumbnail
Vista previa 4 fuera de 68 páginas
Examen

MCE1 S19 Exam – Questions With Insightful Solutions

Document preview thumbnail
Vista previa 4 fuera de 68 páginas

MCE1 S19 Exam – Questions With Insightful Solutions

Vista previa del contenido

MCE1 S19 Exam – Questions With Insightful
Solutions

Save




Terms in this set (167)



Which of the following statements is A. Hepatitis A is transmitted through the fecal-oral
correct regarding the transmission of route, whereas hepatitis B is
hepatitis A, B, transmitted both sexually and via blood, and hepatitis
and C? C is transmitted via blood.


A. Hepatitis A is transmitted through
the fecal-oral route, whereas hepatitis
B is
transmitted both sexually and via
blood, and hepatitis C is transmitted
via blood.
B. Hepatitis A, B, and C are all
transmitted via blood and/or sexual
contact.
C. Hepatitis A and B are transmitted
through the fecal-oral route, and
hepatitis C is
transmitted by blood.
D. Hepatitis A, B, and C are transmitted
through contaminated food or water
and B and
C are also transmitted through blood.

,What is the rationale for prevention of D. All of the above
hepatitis A?


A. Hepatitis A can cause
complications, such as acute liver
failure and death, in patients
with comorbid conditions.
B. Hepatitis A is vaccine preventable.
C. Hepatitis A can have a financial
impact including the costs of
hospitalizations and
indirect losses from loss of work days.
D. All of the above.


Which of the following is most correct B. Vaccination for hepatitis A is preferred because it
regarding the prevention of hepatitis confers lifelong immunity.
A?


A. Postexposure prophylaxis with
immunoglobulin is preferred because
it confers
lifelong immunity.
B. Vaccination for hepatitis A is
preferred because it confers lifelong
immunity.
C. Vaccination is preferred but must
be completed with the same brand of
vaccine.
D. Vaccination is preferred but
requires multiple doses before
conferring immunity.

,As part of a routine workup prior to D. A or B is correct.
initiation of immunosuppressive
therapy, a patient is
found to be HBsAg positive. What are
the implications of this serologic
finding?


A. The patient may have an active
infection with hepatitis B.
B. The patient may have a chronic
infection with hepatitis B.
C. The patient may have received the
hepatitis B vaccine.
D. A or B is correct.
E. A, B, or C is correct


Which of the following statements is A. Patients are at risk of developing end-stage liver
correct regarding patients with disease and cancer even if they do
chronic hepatitis B not have symptoms.
infections?


A. Patients are at risk of developing
end-stage liver disease and cancer
even if they do
not have symptoms.
B. Patients who are infected very early
in life, such as infants, are unlikely to
develop
complications because they are
immune tolerant to the virus.
C. Patients who have chronic infection
should be treated as soon as they are
recognized
to be hepatitis B positive to minimize
the risk of developing end-stage liver
disease and
cancer.
D. All of the above are correct.

, ) Which of the following statements D. All of the above are correct.
best summarizes key concerns in
initiating treatment
for hepatitis B?


A. An HBV viral load and evaluation of
ALT levels should be done to
determine if a
patient should receive treatment or be
managed by periodic monitoring.
B. Prior HBV drug-therapy exposure
should be evaluated because the
choice and
dosage of HBV drug therapy are
different depending on previous
treatment history.
C. The patient's HIV status should be
checked because a number of HBV
drugs also
have activity against HIV.
D. All of the above are correct.


Which of the following statements C. HBV replicates rapidly and mutates easily so
regarding HBV resistance is most ongoing viral suppression is required to
correct? minimize the risk of developing resistance.


A. All of the HBV drugs offer a unique
action against HBV so cross-
resistance is unlikely.
B. Resistance occurs because patients
do not take their medications.
C. HBV replicates rapidly and mutates
easily so ongoing viral suppression is
required to
minimize the risk of developing
resistance.
D. Combination therapy is
implemented because the number of
mutations required to
cause resistance is higher than single-
agent therapy.

Información del documento

Subido en
26 de marzo de 2026
Número de páginas
68
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$34.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
LeCrae
4.0
(445)
Vendido
2116
Seguidores
1409
Artículos
22284
Última venta
5 días hace


Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes